Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
ADMA Biologics Stock (NASDAQ: ADMA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.68K / 3.90M |
Day Range | - - - |
52 Wk Range | 3.06 - 19.34 |
Market Cap | $4.45B |
P/E Ratio | 133.64 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 66 |
Short Interest | 4.2% |
Days to Cover | 3.11 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ADMA Biologics (NASDAQ:ADMA) through any online brokerage.
Other companies in ADMA Biologics’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).
ADMA Biologics has a consensus price target of $15.50.
The stock price for ADMA Biologics (NASDAQ: ADMA) is $19.08 last updated September 18, 2024 at 7:20 AM EDT.
There are no upcoming dividends for ADMA Biologics.
ADMA Biologics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for ADMA Biologics.
ADMA Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.